8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 20, 2008

Longs Drug Stores Corporation

(Exact Name of Registrant as Specified in Charter)

 

Maryland   1-8978   68-0048627

(State or Other Jurisdiction of

Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

141 North Civic Drive

Walnut Creek, California

  94596
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code (925) 937-1170

  

 

(Former Name or Former address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition

(a) On August 20, 2008 Longs Drug Stores Corporation issued a news release regarding its preliminary second quarter fiscal 2009 financial results. The full text of the news release is furnished as an exhibit hereto and incorporated by reference herein. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibit is being furnished as part of this Form 8-K:

 

Number

  

Exhibit

99.1    News Release of Longs Drug Stores Corporation dated August 20, 2008.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 20, 2008     LONGS DRUG STORES CORPORATION
    (Registrant)
    By:   /s/ Roger L. Chelemedos
    Name:   Roger L. Chelemedos
    Its:   Senior Vice President - Finance
      Controller and Treasurer